Prescription Digital Therapeutics is shaping up to be the next big “thing” in the medtech industry. Pear Therapeutics, a company that went public through a Special Purpose Acquisition Corporation merger last year, is at the top of the list of companies in the PDT market, according to analysts of the space.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,